4.6 Article

Restoring connexin-36 function in diabetogenic environments precludes mouse and human islet dysfunction

Journal

JOURNAL OF PHYSIOLOGY-LONDON
Volume 601, Issue 18, Pages 4053-4072

Publisher

WILEY
DOI: 10.1113/JP282114

Keywords

Ca2+; diabetes; gap junctions; islet of Langerhans; peptide mimetic

Ask authors/readers for more resources

The secretion of insulin from beta-cells in the islet of Langerhans is regulated by metabolic and electrical events, which can be disrupted in type 2 diabetes (T2D). Inflammatory cytokines and free fatty acids can disrupt the gap junction coupling between beta-cells, affecting the coordination of calcium dynamics and insulin release. This study investigates the disruption of gap junction coupling and coordinated calcium dynamics in T2D, and explores the potential recovery of islet function through modulating gap junction coupling.
The secretion of insulin from beta-cells in the islet of Langerhans is governed by a series of metabolic and electrical events, which can fail during the progression of type 2 diabetes (T2D). beta-cells are electrically coupled via connexin-36 (Cx36) gap junction channels, which coordinates the pulsatile dynamics of [Ca2+] and insulin release across the islet. Factors such as pro-inflammatory cytokines and free fatty acids disrupt gap junction coupling under in vitro conditions. Here we test whether gap junction coupling and coordinated [Ca2+] dynamics are disrupted inT2D, andwhether recovery of gap junction coupling can recover islet function. We examine islets from donors with T2D, from db/db mice, and islets treated with pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IFN-gamma) or free fatty acids (palmitate). We modulate gap junction coupling using Cx36 over-expression or pharmacological activation via modafinil. We also develop a peptide mimetic (S293) of the c-terminal regulatory site of Cx36 designed to compete against its phosphorylation. Cx36 gap junction permeability and [Ca2+] dynamics were disrupted in islets from both human donors with T2D and db/db mice, and in islets treated with pro-inflammatory cytokines or palmitate. Cx36 over-expression, modafinil treatment and S293 peptide all enhanced Cx36 gap junction coupling and protected against declines in coordinated [Ca2+] dynamics. Cx36 over-expression and S293 peptide also reduced apoptosis induced by pro-inflammatory cytokines. Critically, S293 peptide rescued gap junction coupling and [Ca2+] dynamics in islets fromboth db/db mice and a sub-set of T2D donors. Thus, recovering or enhancing Cx36 gap junction coupling can improve islet function in diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available